HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elangovan Vellaichamy Selected Research

atrial natriuretic factor receptor A

10/2014Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice.
10/2007Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy.
7/2007Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels.
5/2005Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A.
2/2005Reduced cGMP signaling activates NF-kappaB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A.
10/2003Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elangovan Vellaichamy Research Topics

Disease

7Cardiomegaly (Heart Hypertrophy)
10/2017 - 02/2005
7Fibrosis (Cirrhosis)
01/2015 - 02/2005
5Neoplasms (Cancer)
01/2019 - 04/2014
4Body Weight (Weight, Body)
07/2016 - 10/2014
4Heart Failure
07/2007 - 07/2004
2Carcinogenesis
10/2014 - 04/2014
2Hypertrophy
02/2010 - 07/2004
1Colonic Neoplasms (Colon Cancer)
01/2019
1Inflammation (Inflammations)
04/2018
1Weight Gain
04/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Adenocarcinoma of Lung
09/2014
1Diabetes Mellitus
12/2013
1Cardiovascular Diseases (Cardiovascular Disease)
12/2013
1Necrosis
02/2010
1Heart Diseases (Heart Disease)
10/2003

Drug/Important Bio-Agent (IBA)

6atrial natriuretic factor receptor AIBA
10/2014 - 10/2003
5CollagenIBA
11/2014 - 07/2004
4Matrix Metalloproteinases (MMPs)IBA
11/2014 - 05/2005
3CytokinesIBA
04/2018 - 04/2007
3Advanced Glycation End ProductsIBA
04/2018 - 11/2014
3Gallic AcidIBA
04/2018 - 04/2014
3pimagedine (aminoguanidine)IBA
11/2014 - 05/2012
2AntioxidantsIBA
04/2018 - 04/2014
2Atrial Natriuretic Factor (ANF)IBA
10/2017 - 10/2014
2Glucose (Dextrose)FDA LinkGeneric
11/2014 - 05/2012
2Streptozocin (Streptozotocin)FDA Link
11/2014 - 05/2012
2Croton OilIBA
10/2014 - 04/2014
2Guanylate Cyclase (Guanylyl Cyclase)IBA
10/2007 - 05/2005
2NF-kappa B (NF-kB)IBA
05/2005 - 02/2005
1DioxinsIBA
01/2019
13,4-ethylenedioxythiopheneIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1ChemokinesIBA
04/2018
1CurcuminIBA
04/2018
1Pharmaceutical PreparationsIBA
01/2018
1calothrixin BIBA
01/2018
1Biological ProductsIBA
01/2018
1CamptothecinIBA
01/2018
1Indicators and Reagents (Reagents)IBA
07/2016
1Glyoxal (Ethanedial)IBA
01/2015
1Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2014
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2014
1Hormones (Hormone)IBA
10/2014
1SilverIBA
09/2014
1Fluorouracil (Carac)FDA LinkGeneric
04/2014
1AcidsIBA
04/2014
1anthraceneIBA
04/2014
1PhytochemicalsIBA
12/2013
1Interleukin-6 (Interleukin 6)IBA
02/2010
1Collagen Type I (Type I Collagen)IBA
05/2005